Cargando…

Non-adherence to topical treatments for actinic keratosis

BACKGROUND: There is limited information on the patterns of use, adherence rates, and factors that impact adherence with topical treatments for actinic keratosis (AK). OBJECTIVES: To establish patterns of use and adherence with topical treatments for AK and to identify treatment-related factors that...

Descripción completa

Detalles Bibliográficos
Autores principales: Shergill, Bav, Zokaie, Simon, Carr, Alison J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872140/
https://www.ncbi.nlm.nih.gov/pubmed/24379656
http://dx.doi.org/10.2147/PPA.S47126
_version_ 1782296922731577344
author Shergill, Bav
Zokaie, Simon
Carr, Alison J
author_facet Shergill, Bav
Zokaie, Simon
Carr, Alison J
author_sort Shergill, Bav
collection PubMed
description BACKGROUND: There is limited information on the patterns of use, adherence rates, and factors that impact adherence with topical treatments for actinic keratosis (AK). OBJECTIVES: To establish patterns of use and adherence with topical treatments for AK and to identify treatment-related factors that impact on adherence. METHODS: A community-based, cross-sectional study was performed using a standardized questionnaire completed online or via telephone interview. Patients were stratified according to the presence of AK lesions on the scalp and/or other extremities; and presence of scarring resulting from treatment. RESULTS: This study included 305 patients with AK who were currently using a patient-applied topical therapy for AK or had used one within the previous 12 months. In total, 88% (n = 268/305) of patients were either non-adherent, non-persistent or both non-adherent and non-persistent to topical therapy. Duration of treatment was associated with increasing rates of non-adherence (adjusted odds ratio [OR]; for treatment durations greater than 4 weeks, 2.2, P < 0.01): 52% of patients were non-adherent with 3–4 week treatment duration; 69% of patients with 4–8 week treatment duration; and 71% of patients with 6–12 week treatment duration. There were similar increases in non-persistence with increasing treatment duration (adjusted OR; for treatment durations greater than 4 weeks, 2.1, P < 0.05). CONCLUSION: This study found high rates of non-adherence and non-persistence in patients with AK. Duration of treatment was a significant factor contributing to non-adherence and non-persistence to topical treatments. Patient-applied topical therapies that require less frequent application and have shorter treatment duration may be associated with improved adherence rates.
format Online
Article
Text
id pubmed-3872140
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38721402013-12-30 Non-adherence to topical treatments for actinic keratosis Shergill, Bav Zokaie, Simon Carr, Alison J Patient Prefer Adherence Original Research BACKGROUND: There is limited information on the patterns of use, adherence rates, and factors that impact adherence with topical treatments for actinic keratosis (AK). OBJECTIVES: To establish patterns of use and adherence with topical treatments for AK and to identify treatment-related factors that impact on adherence. METHODS: A community-based, cross-sectional study was performed using a standardized questionnaire completed online or via telephone interview. Patients were stratified according to the presence of AK lesions on the scalp and/or other extremities; and presence of scarring resulting from treatment. RESULTS: This study included 305 patients with AK who were currently using a patient-applied topical therapy for AK or had used one within the previous 12 months. In total, 88% (n = 268/305) of patients were either non-adherent, non-persistent or both non-adherent and non-persistent to topical therapy. Duration of treatment was associated with increasing rates of non-adherence (adjusted odds ratio [OR]; for treatment durations greater than 4 weeks, 2.2, P < 0.01): 52% of patients were non-adherent with 3–4 week treatment duration; 69% of patients with 4–8 week treatment duration; and 71% of patients with 6–12 week treatment duration. There were similar increases in non-persistence with increasing treatment duration (adjusted OR; for treatment durations greater than 4 weeks, 2.1, P < 0.05). CONCLUSION: This study found high rates of non-adherence and non-persistence in patients with AK. Duration of treatment was a significant factor contributing to non-adherence and non-persistence to topical treatments. Patient-applied topical therapies that require less frequent application and have shorter treatment duration may be associated with improved adherence rates. Dove Medical Press 2013-12-17 /pmc/articles/PMC3872140/ /pubmed/24379656 http://dx.doi.org/10.2147/PPA.S47126 Text en © 2014 Shergill et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Shergill, Bav
Zokaie, Simon
Carr, Alison J
Non-adherence to topical treatments for actinic keratosis
title Non-adherence to topical treatments for actinic keratosis
title_full Non-adherence to topical treatments for actinic keratosis
title_fullStr Non-adherence to topical treatments for actinic keratosis
title_full_unstemmed Non-adherence to topical treatments for actinic keratosis
title_short Non-adherence to topical treatments for actinic keratosis
title_sort non-adherence to topical treatments for actinic keratosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872140/
https://www.ncbi.nlm.nih.gov/pubmed/24379656
http://dx.doi.org/10.2147/PPA.S47126
work_keys_str_mv AT shergillbav nonadherencetotopicaltreatmentsforactinickeratosis
AT zokaiesimon nonadherencetotopicaltreatmentsforactinickeratosis
AT carralisonj nonadherencetotopicaltreatmentsforactinickeratosis